Concise Review: Altered Versus Unaltered Amniotic Membrane as a Substrate for Limbal Epithelial Cells

Area of Science:

• Ophthalmology
• Regenerative Medicine
• Cell Biology

Background:

• Limbal stem cell deficiency (LSCD) causes corneal damage and vision loss.
• Current treatments include cell transplantation using ex vivo expanded limbal epithelial cells (LEC).
• Amniotic membrane (AM) is a common substrate for LEC expansion, but its preparation is debated.

Purpose of the Study:

• To review the use of altered versus unaltered amniotic membrane (AM) as a substrate for limbal epithelial cell (LEC) culture.
• To discuss how substrate modification affects LEC phenotype and transplantation success in treating LSCD.
• To evaluate the rationale behind using different forms of AM in regenerative medicine for corneal diseases.

Main Methods:

• Literature review of studies on limbal epithelial cell (LEC) expansion on amniotic membrane (AM).
• Analysis of the impact of substrate preparation (denuded vs. intact AM, crosslinking) on LEC phenotype.
• Evaluation of clinical outcomes following transplantation of LEC cultured on various AM substrates.

Main Results:

• The phenotype of cultured LEC is a critical predictor of successful LSCD treatment.
• The choice of culture substrate, including amniotic membrane (AM) preparation, influences LEC phenotype.
• Crosslinking AM enhances its stability and optical properties for potential use in LEC culture.

Conclusions:

• Both altered and unaltered amniotic membrane (AM) can be used as substrates for limbal epithelial cell (LEC) expansion.
• Further research is needed to determine the optimal AM preparation for maximizing LEC function and transplantation success.
• Understanding substrate effects on LEC is crucial for advancing regenerative therapies for LSCD.